BIO-KEY INTERNATIONAL INC (BKYI)
US09060C5076 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 307.09K | 2.64M | 7.75M | 16.99M | 80.00K | |||
| Marketable Securities | N/A | N/A | 0.00 | 510.00K | 510.00K | |||
| Receivables | 2.86M | 1.57M | 1.10M | 900.00K | 240.00K | |||
| Inventories | 4.29M | 4.43M | 4.94M | 330.00K | 430.00K | |||
| Other Current Assets | 362.25K | 340.00K | 220.00K | 200.00K | 110.00K | |||
| Total Current Assets | 7.82M | 8.98M | 14.01M | 18.94M | 1.37M | |||
| Non-Current Assets | ||||||||
| PPE Net | 119.67K | 300.00K | 320.00K | 570.00K | 660.00K | |||
| Investments And Advances | N/A | N/A | 450.00K | N/A | N/A | |||
| Goodwill | N/A | N/A | 1.26M | 1.26M | N/A | |||
| Intangibles | 1.52M | 1.76M | 1.35M | 1.57M | 230.00K | |||
| Other Non-Current Assets | 289.78K | 290.00K | 260.00K | 170.00K | 240.00K | |||
| Total Non-Current Assets | 1.93M | 2.36M | 3.76M | 3.58M | 1.13M | |||
| TOTAL ASSETS | 9.75M | 11.34M | 17.77M | 22.52M | 2.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 2.33M | 2.60M | 0.00 | 230.00K | 2.26M | |||
| Current Portion Of LT Debt. | 135.31K | 120.00K | N/A | N/A | N/A | |||
| Accrued Expenses | 1.13M | 1.17M | 1.01M | 740.00K | 860.00K | |||
| Accounts Payable | 1.66M | 1.11M | 430.00K | 240.00K | 920.00K | |||
| Other Current Liabilities | 773.26K | 460.00K | 570.00K | 660.00K | 360.00K | |||
| Total Current Liabilities | 6.03M | 5.46M | 2.00M | 1.88M | 4.39M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 221.63K | 330.00K | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 153.00K | 170.00K | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 32.35K | 90.00K | 150.00K | 310.00K | 390.00K | |||
| Total Non-Current Liabilities | 406.98K | 580.00K | 150.00K | 310.00K | 390.00K | |||
| TOTAL LIABILITIES | 6.43M | 6.04M | 2.15M | 2.19M | 4.78M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -118.83M | -116.49M | -104.58M | -99.51M | -89.72M | |||
| Additional Paid In Capital | 122.26M | 122.03M | 120.19M | 119.84M | 87.44M | |||
| Common Shares | 950.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -115.21K | -240.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 527.91K | 9.19M | 7.85M | 7.81M | 1.80M | |||
| Tangible Book Value per Share | 3.40 | 0.39 | 1.66 | 2.24 | -1.40 | |||
| Total Shareholders' Equity | 3.31M | 5.30M | 15.62M | 20.34M | -2.29M | |||
| TOTAL LIABILITIES AND EQUITY | 9.75M | 11.34M | 17.77M | 22.52M | 2.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.77 | 0.55 | N/A | N/A | N/A | |||
| Current Ratio | 1.30 | 1.64 | 7.00 | 10.07 | 0.31 | |||
| Return On Assets (ROA) | -93.73% | -105.03% | -28.53% | -43.47% | -583.60% | |||
| Return On Equity (ROE) | -275.70% | -224.72% | -32.46% | -48.13% | N/A | |||
All data in USD